InvestorsHub Logo
Followers 467
Posts 26918
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 111

Thursday, 02/07/2013 8:43:34 AM

Thursday, February 07, 2013 8:43:34 AM

Post# of 145
7:49AM On The Wires (WIRES) :Dyax (DYAX) and CVie Therapeutics, a subsidiary of Lee's Pharmaceutical Holdings, announced a strategic partnership for the development and commercialization of KALBITOR (ecallantide) in the treatment of hereditary angioedema and other angioedema indications in China, Hong Kong and Macau.